Norwich, UK — Plant Bioscience Limited (PBL), a technology development and intellectual property (IP) management company, announced today that it has entered into a licensing agreement that grants Thermo Fisher Scientific a world-wide, non-exclusive license to the Baulcombe patents (U.S. Patent Nos. 6,753,139, 7,704,688, 8,097,710, 8,258,285, 8,263,569, 8,299,235, 8,349,607, 8,759,102 and 8,779,236) for use in the field of research reagents and kits. Financial terms were not disclosed.

PBL’s Managing Director Dr Jan Chojecki, stated: “We are very pleased to enter into this agreement with Thermo Fisher, a global leader in research reagents based on RNA interference and detecting gene silencing. Thermo Fisher has an excellent product portfolio in this important and growing area of science. We look forward to working with other partners through our non-exclusive licensing strategy in agricultural, research, diagnostic and therapeutic commercial applications. We are pleased to be able to make non-exclusive licenses available on reasonable commercial terms to assist our partners in all areas of RNAi.”